English
简体中文
Total: £ 56.28
Published Date: 2026-04-13 | Pages: 133 | Tables: 129 | Pharma & Healthcare
The global Drugs to Treat Allergic Diseases market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Drugs to Treat Allergic Diseases competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Drugs used to treat allergic diseases refer to a class of drugs used to reduce the symptoms of allergic reactions, control inflammatory reactions, or enhance the immune system's tolerance to allergens. These drugs can be used to treat various allergic diseases, including allergic rhinitis, allergic asthma, atopic dermatitis, allergic conjunctivitis, etc. Drugs used to treat allergic diseases can achieve their therapeutic goals through different mechanisms of action. For example, antihistamines can block the effects of histamine, thereby alleviating symptoms; glucocorticoids can inhibit inflammatory responses; immunotherapy can reduce allergic reactions by gradually exposing the body to allergens. The choice of different drugs depends on the severity of the condition, the individual patient's condition, and the goals of treatment.
The North American market for Drugs to Treat Allergic Diseases is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Drugs to Treat Allergic Diseases is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Drugs to Treat Allergic Diseases include Mylan, Bayer, UCB Pharma, J&J, Perrigo, GSK, Kaleo, Amneal Pharma, ALK Abello, Aimmune Therapeutics, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Drugs to Treat Allergic Diseases market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Drugs to Treat Allergic Diseases. The Drugs to Treat Allergic Diseases market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Drugs to Treat Allergic Diseases market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Drugs to Treat Allergic Diseases manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Mylan
Bayer
UCB Pharma
J&J
Perrigo
GSK
Kaleo
Amneal Pharma
ALK Abello
Aimmune Therapeutics
Chongqing Huabang Pharmaceutical Co., Ltd.
Allergy Therapeutics
ASIT Biotech
Sanofi
DBV Technologies
HAL Allergy
Intrommune Therapeutics
Segment by Type
Epinephrine Injection
Antihistamines
Oral Immunotherapy
Other
by Application
Hospital Pharmacy
Retail Pharmacy
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Drugs to Treat Allergic Diseases manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Drugs to Treat Allergic Diseases sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Drugs to Treat Allergic Diseases Market Overview
1.1 Product Definition
1.2 Drugs to Treat Allergic Diseases by Type
1.2.1 Global Drugs to Treat Allergic Diseases Market Value by Type: 2025 vs 2032
1.2.2 Epinephrine Injection
1.2.3 Antihistamines
1.2.4 Oral Immunotherapy
1.2.5 Other
1.3 Drugs to Treat Allergic Diseases by Application
1.3.1 Global Drugs to Treat Allergic Diseases Market Value by Application: 2025 vs 2032
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Global Drugs to Treat Allergic Diseases Market Size Estimates and Forecasts
1.4.1 Global Drugs to Treat Allergic Diseases Revenue 2021–2032
1.4.2 Global Drugs to Treat Allergic Diseases Sales 2021–2032
1.4.3 Global Drugs to Treat Allergic Diseases Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Drugs to Treat Allergic Diseases Market Competition by Manufacturers
2.1 Global Drugs to Treat Allergic Diseases Sales Market Share by Manufacturers (2021–2026)
2.2 Global Drugs to Treat Allergic Diseases Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Drugs to Treat Allergic Diseases Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Drugs to Treat Allergic Diseases, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Drugs to Treat Allergic Diseases, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Drugs to Treat Allergic Diseases, Product Types and Applications
2.7 Global Key Manufacturers of Drugs to Treat Allergic Diseases, Date of Entry into the Industry
2.8 Global Drugs to Treat Allergic Diseases Market Competitive Situation and Trends
2.8.1 Global Drugs to Treat Allergic Diseases Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Drugs to Treat Allergic Diseases Players Market Share by Revenue
2.8.3 Global Drugs to Treat Allergic Diseases Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Drugs to Treat Allergic Diseases Market Scenario by Region
3.1 Global Drugs to Treat Allergic Diseases Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Drugs to Treat Allergic Diseases Sales by Region: 2021–2032
3.2.1 Global Drugs to Treat Allergic Diseases Sales by Region: 2021–2026
3.2.2 Global Drugs to Treat Allergic Diseases Sales by Region: 2027–2032
3.3 Global Drugs to Treat Allergic Diseases Revenue by Region: 2021–2032
3.3.1 Global Drugs to Treat Allergic Diseases Revenue by Region: 2021–2026
3.3.2 Global Drugs to Treat Allergic Diseases Revenue by Region: 2027–2032
3.4 North America Drugs to Treat Allergic Diseases Market Facts & Figures by Country
3.4.1 North America Drugs to Treat Allergic Diseases Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Drugs to Treat Allergic Diseases Sales by Country (2021–2032)
3.4.3 North America Drugs to Treat Allergic Diseases Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Drugs to Treat Allergic Diseases Market Facts & Figures by Country
3.5.1 Europe Drugs to Treat Allergic Diseases Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Drugs to Treat Allergic Diseases Sales by Country (2021–2032)
3.5.3 Europe Drugs to Treat Allergic Diseases Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Drugs to Treat Allergic Diseases Market Facts & Figures by Region
3.6.1 Asia Pacific Drugs to Treat Allergic Diseases Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Drugs to Treat Allergic Diseases Sales by Region (2021–2032)
3.6.3 Asia Pacific Drugs to Treat Allergic Diseases Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Drugs to Treat Allergic Diseases Market Facts & Figures by Country
3.7.1 Latin America Drugs to Treat Allergic Diseases Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Drugs to Treat Allergic Diseases Sales by Country (2021–2032)
3.7.3 Latin America Drugs to Treat Allergic Diseases Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Drugs to Treat Allergic Diseases Market Facts & Figures by Country
3.8.1 Middle East and Africa Drugs to Treat Allergic Diseases Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Drugs to Treat Allergic Diseases Sales by Country (2021–2032)
3.8.3 Middle East and Africa Drugs to Treat Allergic Diseases Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Drugs to Treat Allergic Diseases Sales by Type (2021–2032)
4.1.1 Global Drugs to Treat Allergic Diseases Sales by Type (2021–2026)
4.1.2 Global Drugs to Treat Allergic Diseases Sales by Type (2027–2032)
4.1.3 Global Drugs to Treat Allergic Diseases Sales Market Share by Type (2021–2032)
4.2 Global Drugs to Treat Allergic Diseases Revenue by Type (2021–2032)
4.2.1 Global Drugs to Treat Allergic Diseases Revenue by Type (2021–2026)
4.2.2 Global Drugs to Treat Allergic Diseases Revenue by Type (2027–2032)
4.2.3 Global Drugs to Treat Allergic Diseases Revenue Market Share by Type (2021–2032)
4.3 Global Drugs to Treat Allergic Diseases Price by Type (2021–2032)
5 Segment by Application
5.1 Global Drugs to Treat Allergic Diseases Sales by Application (2021–2032)
5.1.1 Global Drugs to Treat Allergic Diseases Sales by Application (2021–2026)
5.1.2 Global Drugs to Treat Allergic Diseases Sales by Application (2027–2032)
5.1.3 Global Drugs to Treat Allergic Diseases Sales Market Share by Application (2021–2032)
5.2 Global Drugs to Treat Allergic Diseases Revenue by Application (2021–2032)
5.2.1 Global Drugs to Treat Allergic Diseases Revenue by Application (2021–2026)
5.2.2 Global Drugs to Treat Allergic Diseases Revenue by Application (2027–2032)
5.2.3 Global Drugs to Treat Allergic Diseases Revenue Market Share by Application (2021–2032)
5.3 Global Drugs to Treat Allergic Diseases Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Mylan
6.1.1 Mylan Company Information
6.1.2 Mylan Description and Business Overview
6.1.3 Mylan Drugs to Treat Allergic Diseases Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Mylan Drugs to Treat Allergic Diseases Product Portfolio
6.1.5 Mylan Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Company Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Drugs to Treat Allergic Diseases Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Bayer Drugs to Treat Allergic Diseases Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 UCB Pharma
6.3.1 UCB Pharma Company Information
6.3.2 UCB Pharma Description and Business Overview
6.3.3 UCB Pharma Drugs to Treat Allergic Diseases Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 UCB Pharma Drugs to Treat Allergic Diseases Product Portfolio
6.3.5 UCB Pharma Recent Developments/Updates
6.4 J&J
6.4.1 J&J Company Information
6.4.2 J&J Description and Business Overview
6.4.3 J&J Drugs to Treat Allergic Diseases Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 J&J Drugs to Treat Allergic Diseases Product Portfolio
6.4.5 J&J Recent Developments/Updates
6.5 Perrigo
6.5.1 Perrigo Company Information
6.5.2 Perrigo Description and Business Overview
6.5.3 Perrigo Drugs to Treat Allergic Diseases Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Perrigo Drugs to Treat Allergic Diseases Product Portfolio
6.5.5 Perrigo Recent Developments/Updates
6.6 GSK
6.6.1 GSK Company Information
6.6.2 GSK Description and Business Overview
6.6.3 GSK Drugs to Treat Allergic Diseases Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 GSK Drugs to Treat Allergic Diseases Product Portfolio
6.6.5 GSK Recent Developments/Updates
6.7 Kaleo
6.7.1 Kaleo Company Information
6.7.2 Kaleo Description and Business Overview
6.7.3 Kaleo Drugs to Treat Allergic Diseases Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Kaleo Drugs to Treat Allergic Diseases Product Portfolio
6.7.5 Kaleo Recent Developments/Updates
6.8 Amneal Pharma
6.8.1 Amneal Pharma Company Information
6.8.2 Amneal Pharma Description and Business Overview
6.8.3 Amneal Pharma Drugs to Treat Allergic Diseases Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Amneal Pharma Drugs to Treat Allergic Diseases Product Portfolio
6.8.5 Amneal Pharma Recent Developments/Updates
6.9 ALK Abello
6.9.1 ALK Abello Company Information
6.9.2 ALK Abello Description and Business Overview
6.9.3 ALK Abello Drugs to Treat Allergic Diseases Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 ALK Abello Drugs to Treat Allergic Diseases Product Portfolio
6.9.5 ALK Abello Recent Developments/Updates
6.10 Aimmune Therapeutics
6.10.1 Aimmune Therapeutics Company Information
6.10.2 Aimmune Therapeutics Description and Business Overview
6.10.3 Aimmune Therapeutics Drugs to Treat Allergic Diseases Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Aimmune Therapeutics Drugs to Treat Allergic Diseases Product Portfolio
6.10.5 Aimmune Therapeutics Recent Developments/Updates
6.11 Chongqing Huabang Pharmaceutical Co., Ltd.
6.11.1 Chongqing Huabang Pharmaceutical Co., Ltd. Company Information
6.11.2 Chongqing Huabang Pharmaceutical Co., Ltd. Description and Business Overview
6.11.3 Chongqing Huabang Pharmaceutical Co., Ltd. Drugs to Treat Allergic Diseases Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Chongqing Huabang Pharmaceutical Co., Ltd. Drugs to Treat Allergic Diseases Product Portfolio
6.11.5 Chongqing Huabang Pharmaceutical Co., Ltd. Recent Developments/Updates
6.12 Allergy Therapeutics
6.12.1 Allergy Therapeutics Company Information
6.12.2 Allergy Therapeutics Description and Business Overview
6.12.3 Allergy Therapeutics Drugs to Treat Allergic Diseases Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Allergy Therapeutics Drugs to Treat Allergic Diseases Product Portfolio
6.12.5 Allergy Therapeutics Recent Developments/Updates
6.13 ASIT Biotech
6.13.1 ASIT Biotech Company Information
6.13.2 ASIT Biotech Description and Business Overview
6.13.3 ASIT Biotech Drugs to Treat Allergic Diseases Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 ASIT Biotech Drugs to Treat Allergic Diseases Product Portfolio
6.13.5 ASIT Biotech Recent Developments/Updates
6.14 Sanofi
6.14.1 Sanofi Company Information
6.14.2 Sanofi Description and Business Overview
6.14.3 Sanofi Drugs to Treat Allergic Diseases Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Sanofi Drugs to Treat Allergic Diseases Product Portfolio
6.14.5 Sanofi Recent Developments/Updates
6.15 DBV Technologies
6.15.1 DBV Technologies Company Information
6.15.2 DBV Technologies Description and Business Overview
6.15.3 DBV Technologies Drugs to Treat Allergic Diseases Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 DBV Technologies Drugs to Treat Allergic Diseases Product Portfolio
6.15.5 DBV Technologies Recent Developments/Updates
6.16 HAL Allergy
6.16.1 HAL Allergy Company Information
6.16.2 HAL Allergy Description and Business Overview
6.16.3 HAL Allergy Drugs to Treat Allergic Diseases Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 HAL Allergy Drugs to Treat Allergic Diseases Product Portfolio
6.16.5 HAL Allergy Recent Developments/Updates
6.17 Intrommune Therapeutics
6.17.1 Intrommune Therapeutics Company Information
6.17.2 Intrommune Therapeutics Description and Business Overview
6.17.3 Intrommune Therapeutics Drugs to Treat Allergic Diseases Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Intrommune Therapeutics Drugs to Treat Allergic Diseases Product Portfolio
6.17.5 Intrommune Therapeutics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Drugs to Treat Allergic Diseases Industry Chain Analysis
7.2 Drugs to Treat Allergic Diseases Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Drugs to Treat Allergic Diseases Production Mode & Process Analysis
7.4 Drugs to Treat Allergic Diseases Sales and Marketing
7.4.1 Drugs to Treat Allergic Diseases Sales Channels
7.4.2 Drugs to Treat Allergic Diseases Distributors
7.5 Drugs to Treat Allergic Diseases Customer Analysis
8 Drugs to Treat Allergic Diseases Market Dynamics
8.1 Drugs to Treat Allergic Diseases Industry Trends
8.2 Drugs to Treat Allergic Diseases Market Drivers
8.3 Drugs to Treat Allergic Diseases Market Challenges
8.4 Drugs to Treat Allergic Diseases Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Drugs to Treat Allergic Diseases Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Drugs to Treat Allergic Diseases Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Drugs to Treat Allergic Diseases Market Competitive Situation by Manufacturers in 2025
Table 4. Global Drugs to Treat Allergic Diseases Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Drugs to Treat Allergic Diseases Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Drugs to Treat Allergic Diseases Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Drugs to Treat Allergic Diseases Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Drugs to Treat Allergic Diseases Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Drugs to Treat Allergic Diseases, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Drugs to Treat Allergic Diseases, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Drugs to Treat Allergic Diseases, Product Types and Applications
Table 12. Global Key Manufacturers of Drugs to Treat Allergic Diseases, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Drugs to Treat Allergic Diseases Companies by Tier (Tier 1, Tier 2, Tier 3), based on Drugs to Treat Allergic Diseases Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Drugs to Treat Allergic Diseases Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Drugs to Treat Allergic Diseases Sales by Region (K Units), 2021–2026
Table 18. Global Drugs to Treat Allergic Diseases Sales Market Share by Region (2021–2026)
Table 19. Global Drugs to Treat Allergic Diseases Sales by Region (K Units), 2027–2032
Table 20. Global Drugs to Treat Allergic Diseases Sales Market Share by Region (2027–2032)
Table 21. Global Drugs to Treat Allergic Diseases Revenue by Region (US$ Million), 2021–2026
Table 22. Global Drugs to Treat Allergic Diseases Revenue Market Share by Region (2021–2026)
Table 23. Global Drugs to Treat Allergic Diseases Revenue by Region (US$ Million), 2027–2032
Table 24. Global Drugs to Treat Allergic Diseases Revenue Market Share by Region (2027–2032)
Table 25. North America Drugs to Treat Allergic Diseases Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Drugs to Treat Allergic Diseases Sales by Country (K Units), 2021–2026
Table 27. North America Drugs to Treat Allergic Diseases Sales by Country (K Units), 2027–2032
Table 28. North America Drugs to Treat Allergic Diseases Revenue by Country (US$ Million), 2021–2026
Table 29. North America Drugs to Treat Allergic Diseases Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Drugs to Treat Allergic Diseases Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Drugs to Treat Allergic Diseases Sales by Country (K Units), 2021–2026
Table 32. Europe Drugs to Treat Allergic Diseases Sales by Country (K Units), 2027–2032
Table 33. Europe Drugs to Treat Allergic Diseases Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Drugs to Treat Allergic Diseases Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Drugs to Treat Allergic Diseases Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Drugs to Treat Allergic Diseases Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Drugs to Treat Allergic Diseases Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Drugs to Treat Allergic Diseases Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Drugs to Treat Allergic Diseases Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Drugs to Treat Allergic Diseases Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Drugs to Treat Allergic Diseases Sales by Country (K Units), 2021–2026
Table 42. Latin America Drugs to Treat Allergic Diseases Sales by Country (K Units), 2027–2032
Table 43. Latin America Drugs to Treat Allergic Diseases Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Drugs to Treat Allergic Diseases Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Drugs to Treat Allergic Diseases Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Drugs to Treat Allergic Diseases Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Drugs to Treat Allergic Diseases Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Drugs to Treat Allergic Diseases Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Drugs to Treat Allergic Diseases Revenue by Country (US$ Million), 2027–2032
Table 50. Global Drugs to Treat Allergic Diseases Sales (K Units) by Type (2021–2026)
Table 51. Global Drugs to Treat Allergic Diseases Sales (K Units) by Type (2027–2032)
Table 52. Global Drugs to Treat Allergic Diseases Sales Market Share by Type (2021–2026)
Table 53. Global Drugs to Treat Allergic Diseases Sales Market Share by Type (2027–2032)
Table 54. Global Drugs to Treat Allergic Diseases Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Drugs to Treat Allergic Diseases Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Drugs to Treat Allergic Diseases Revenue Market Share by Type (2021–2026)
Table 57. Global Drugs to Treat Allergic Diseases Revenue Market Share by Type (2027–2032)
Table 58. Global Drugs to Treat Allergic Diseases Price (US$/Unit) by Type (2021–2026)
Table 59. Global Drugs to Treat Allergic Diseases Price (US$/Unit) by Type (2027–2032)
Table 60. Global Drugs to Treat Allergic Diseases Sales (K Units) by Application (2021–2026)
Table 61. Global Drugs to Treat Allergic Diseases Sales (K Units) by Application (2027–2032)
Table 62. Global Drugs to Treat Allergic Diseases Sales Market Share by Application (2021–2026)
Table 63. Global Drugs to Treat Allergic Diseases Sales Market Share by Application (2027–2032)
Table 64. Global Drugs to Treat Allergic Diseases Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Drugs to Treat Allergic Diseases Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Drugs to Treat Allergic Diseases Revenue Market Share by Application (2021–2026)
Table 67. Global Drugs to Treat Allergic Diseases Revenue Market Share by Application (2027–2032)
Table 68. Global Drugs to Treat Allergic Diseases Price (US$/Unit) by Application (2021–2026)
Table 69. Global Drugs to Treat Allergic Diseases Price (US$/Unit) by Application (2027–2032)
Table 70. Mylan Company Information
Table 71. Mylan Description and Business Overview
Table 72. Mylan Drugs to Treat Allergic Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Mylan Drugs to Treat Allergic Diseases Product
Table 74. Mylan Recent Developments/Updates
Table 75. Bayer Company Information
Table 76. Bayer Description and Business Overview
Table 77. Bayer Drugs to Treat Allergic Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Bayer Drugs to Treat Allergic Diseases Product
Table 79. Bayer Recent Developments/Updates
Table 80. UCB Pharma Company Information
Table 81. UCB Pharma Description and Business Overview
Table 82. UCB Pharma Drugs to Treat Allergic Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. UCB Pharma Drugs to Treat Allergic Diseases Product
Table 84. UCB Pharma Recent Developments/Updates
Table 85. J&J Company Information
Table 86. J&J Description and Business Overview
Table 87. J&J Drugs to Treat Allergic Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. J&J Drugs to Treat Allergic Diseases Product
Table 89. J&J Recent Developments/Updates
Table 90. Perrigo Company Information
Table 91. Perrigo Description and Business Overview
Table 92. Perrigo Drugs to Treat Allergic Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Perrigo Drugs to Treat Allergic Diseases Product
Table 94. Perrigo Recent Developments/Updates
Table 95. GSK Company Information
Table 96. GSK Description and Business Overview
Table 97. GSK Drugs to Treat Allergic Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. GSK Drugs to Treat Allergic Diseases Product
Table 99. GSK Recent Developments/Updates
Table 100. Kaleo Company Information
Table 101. Kaleo Description and Business Overview
Table 102. Kaleo Drugs to Treat Allergic Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Kaleo Drugs to Treat Allergic Diseases Product
Table 104. Kaleo Recent Developments/Updates
Table 105. Amneal Pharma Company Information
Table 106. Amneal Pharma Description and Business Overview
Table 107. Amneal Pharma Drugs to Treat Allergic Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Amneal Pharma Drugs to Treat Allergic Diseases Product
Table 109. Amneal Pharma Recent Developments/Updates
Table 110. ALK Abello Company Information
Table 111. ALK Abello Description and Business Overview
Table 112. ALK Abello Drugs to Treat Allergic Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. ALK Abello Drugs to Treat Allergic Diseases Product
Table 114. ALK Abello Recent Developments/Updates
Table 115. Aimmune Therapeutics Company Information
Table 116. Aimmune Therapeutics Description and Business Overview
Table 117. Aimmune Therapeutics Drugs to Treat Allergic Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Aimmune Therapeutics Drugs to Treat Allergic Diseases Product
Table 119. Aimmune Therapeutics Recent Developments/Updates
Table 120. Chongqing Huabang Pharmaceutical Co., Ltd. Company Information
Table 121. Chongqing Huabang Pharmaceutical Co., Ltd. Description and Business Overview
Table 122. Chongqing Huabang Pharmaceutical Co., Ltd. Drugs to Treat Allergic Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Chongqing Huabang Pharmaceutical Co., Ltd. Drugs to Treat Allergic Diseases Product
Table 124. Chongqing Huabang Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 125. Allergy Therapeutics Company Information
Table 126. Allergy Therapeutics Description and Business Overview
Table 127. Allergy Therapeutics Drugs to Treat Allergic Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Allergy Therapeutics Drugs to Treat Allergic Diseases Product
Table 129. Allergy Therapeutics Recent Developments/Updates
Table 130. ASIT Biotech Company Information
Table 131. ASIT Biotech Description and Business Overview
Table 132. ASIT Biotech Drugs to Treat Allergic Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. ASIT Biotech Drugs to Treat Allergic Diseases Product
Table 134. ASIT Biotech Recent Developments/Updates
Table 135. Sanofi Company Information
Table 136. Sanofi Description and Business Overview
Table 137. Sanofi Drugs to Treat Allergic Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Sanofi Drugs to Treat Allergic Diseases Product
Table 139. Sanofi Recent Developments/Updates
Table 140. DBV Technologies Company Information
Table 141. DBV Technologies Description and Business Overview
Table 142. DBV Technologies Drugs to Treat Allergic Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. DBV Technologies Drugs to Treat Allergic Diseases Product
Table 144. DBV Technologies Recent Developments/Updates
Table 145. HAL Allergy Company Information
Table 146. HAL Allergy Description and Business Overview
Table 147. HAL Allergy Drugs to Treat Allergic Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 148. HAL Allergy Drugs to Treat Allergic Diseases Product
Table 149. HAL Allergy Recent Developments/Updates
Table 150. Intrommune Therapeutics Company Information
Table 151. Intrommune Therapeutics Description and Business Overview
Table 152. Intrommune Therapeutics Drugs to Treat Allergic Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 153. Intrommune Therapeutics Drugs to Treat Allergic Diseases Product
Table 154. Intrommune Therapeutics Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Drugs to Treat Allergic Diseases Distributors List
Table 158. Drugs to Treat Allergic Diseases Customers List
Table 159. Drugs to Treat Allergic Diseases Market Trends
Table 160. Drugs to Treat Allergic Diseases Market Drivers
Table 161. Drugs to Treat Allergic Diseases Market Challenges
Table 162. Drugs to Treat Allergic Diseases Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report
List of Figures
Figure 1. Product Picture of Drugs to Treat Allergic Diseases
Figure 2. Global Drugs to Treat Allergic Diseases Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Drugs to Treat Allergic Diseases Market Share by Type: 2025 & 2032
Figure 4. Epinephrine Injection Product Picture
Figure 5. Antihistamines Product Picture
Figure 6. Oral Immunotherapy Product Picture
Figure 7. Other Product Picture
Figure 8. Global Drugs to Treat Allergic Diseases Market Value by Application (US$ Million), 2021–2032
Figure 9. Global Drugs to Treat Allergic Diseases Market Share by Application: 2025 & 2032
Figure 10. Hospital Pharmacy
Figure 11. Retail Pharmacy
Figure 12. Other
Figure 13. Global Drugs to Treat Allergic Diseases Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Drugs to Treat Allergic Diseases Market Size (US$ Million), 2021–2032
Figure 15. Global Drugs to Treat Allergic Diseases Sales (K Units), 2021–2032
Figure 16. Global Drugs to Treat Allergic Diseases Average Price (US$/Unit), 2021–2032
Figure 17. Drugs to Treat Allergic Diseases Report Years Considered
Figure 18. Drugs to Treat Allergic Diseases Sales Share by Manufacturers in 2025
Figure 19. Global Drugs to Treat Allergic Diseases Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global Drugs to Treat Allergic Diseases Players: Market Share by Revenue in Drugs to Treat Allergic Diseases in 2025
Figure 21. Drugs to Treat Allergic Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global Drugs to Treat Allergic Diseases Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America Drugs to Treat Allergic Diseases Sales Market Share by Country (2021–2032)
Figure 24. North America Drugs to Treat Allergic Diseases Revenue Market Share by Country (2021–2032)
Figure 25. United States Drugs to Treat Allergic Diseases Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada Drugs to Treat Allergic Diseases Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe Drugs to Treat Allergic Diseases Sales Market Share by Country (2021–2032)
Figure 28. Europe Drugs to Treat Allergic Diseases Revenue Market Share by Country (2021–2032)
Figure 29. Germany Drugs to Treat Allergic Diseases Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France Drugs to Treat Allergic Diseases Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. Drugs to Treat Allergic Diseases Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy Drugs to Treat Allergic Diseases Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia Drugs to Treat Allergic Diseases Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific Drugs to Treat Allergic Diseases Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific Drugs to Treat Allergic Diseases Revenue Market Share by Region (2021–2032)
Figure 36. China Drugs to Treat Allergic Diseases Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan Drugs to Treat Allergic Diseases Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea Drugs to Treat Allergic Diseases Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India Drugs to Treat Allergic Diseases Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia Drugs to Treat Allergic Diseases Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan Drugs to Treat Allergic Diseases Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Southeast Asia Drugs to Treat Allergic Diseases Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America Drugs to Treat Allergic Diseases Sales Market Share by Country (2021–2032)
Figure 44. Latin America Drugs to Treat Allergic Diseases Revenue Market Share by Country (2021–2032)
Figure 45. Mexico Drugs to Treat Allergic Diseases Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil Drugs to Treat Allergic Diseases Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina Drugs to Treat Allergic Diseases Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Colombia Drugs to Treat Allergic Diseases Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa Drugs to Treat Allergic Diseases Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa Drugs to Treat Allergic Diseases Revenue Market Share by Country (2021–2032)
Figure 51. Turkey Drugs to Treat Allergic Diseases Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia Drugs to Treat Allergic Diseases Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE Drugs to Treat Allergic Diseases Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of Drugs to Treat Allergic Diseases by Type (2021–2032)
Figure 55. Global Revenue Market Share of Drugs to Treat Allergic Diseases by Type (2021–2032)
Figure 56. Global Drugs to Treat Allergic Diseases Price (US$/Unit) by Type (2021–2032)
Figure 57. Global Sales Market Share of Drugs to Treat Allergic Diseases by Application (2021–2032)
Figure 58. Global Revenue Market Share of Drugs to Treat Allergic Diseases by Application (2021–2032)
Figure 59. Global Drugs to Treat Allergic Diseases Price (US$/Unit) by Application (2021–2032)
Figure 60. Drugs to Treat Allergic Diseases Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
